Immediate Impact

1 by Nobel laureates 59 standout
Sub-graph 1 of 22

Citing Papers

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2024 Standout
Renal Cell Carcinoma
2024 Standout
2 intermediate papers

Works of Samuel Broderick being referenced

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
2016
Heart Failure With Preserved Ejection Fraction
2013

Author Peers

Author Last Decade Papers Cites
Samuel Broderick 270 85 130 308 268 23 684
Nicholas Jenkins 262 26 242 140 96 23 652
Thomas Walsh 363 148 112 278 89 26 765
Erwin Robin 210 40 111 115 176 33 826
Benjamin E. Haithcock 141 52 256 421 168 47 809
Liana Zucco 180 10 139 263 311 16 760
Jinxian He 61 37 122 141 462 26 757
Deepak Hariharan 109 50 390 181 219 21 836
Alykhan S. Nagji 78 36 327 198 182 24 716
John C. Densmore 96 17 301 194 276 26 830
Josep María Gimferrer 91 45 107 448 138 25 675

All Works

Loading papers...

Rankless by CCL
2026